Skip to main content
Year archive

PRESCIENT THERAPEUTICS LIMITED — 2016 filings

All 65 regulatory filings released by PRESCIENT THERAPEUTICS LIMITED (PTX) in 2016, sourced directly from the official regulator.

65 Filings
2016 Period
2016 filings (65)
Filing Released Lang
Section 708A Cleansing Notice and Appendix 3B 13 pages 663.4KB
Share Issue/Capital Change
2016-12-20 English
Change of Director's Interest Notices x4 9 pages 481.1KB
Director's Dealing
2016-12-20 English
Change of Registry Address 1 page 102.4KB
Regulatory Filings
2016-12-15 English
First Patient Dosed on Phase 1b/2 AML Trial 4 pages 118.3KB
Regulatory Filings
2016-12-13 English
Phase 1b/2 Ovarian Trial Commences 2nd Dose Escalation 2 pages 413.1KB
Regulatory Filings
2016-12-07 English
Results of Annual General Meeting 2 pages 321.7KB
Declaration of Voting Results & Voting Rights Announcements
2016-11-29 English
Change of Director's Interest Notice 4 pages 272.1KB
Director's Dealing
2016-11-08 English
Receipt of R&D Tax Rebate 1 page 210.0KB
Regulatory Filings
2016-11-01 English
September 2016 Appendix 4C - Quarterly 8 pages 371.4KB
Interim / Quarterly Report
2016-10-27 English
Notice of Annual General Meeting/Proxy Form 26 pages 1.6MB
AGM Information
2016-10-27 English
Response to ASX Price Query 4 pages 735.0KB
Regulatory Filings
2016-10-18 English
First patient at Moffitt dosed in Phase 1b/2 breast trial 2 pages 228.0KB
Regulatory Filings
2016-09-25 English
PTX presents at Rodman & Renshaw Investment conference 2 pages 274.5KB
Investor Presentation
2016-09-12 English
Rodman & Renshaw Global Investment conference Presentation 33 pages 3.8MB
Investor Presentation
2016-09-12 English
Appendix 3B 12 pages 526.5KB
Share Issue/Capital Change
2016-09-11 English
Appendix 4E and 2016 Annual Report 54 pages 828.6KB
Annual Report
2016-08-30 English
Appendix 4G and Corporate Governance Statement 23 pages 989.9KB
Governance Information
2016-08-30 English
Section 708A Cleansing Notice and Appendix 3B 14 pages 346.2KB
Capital/Financing Update
2016-08-15 English
USPTO Grants Allowances for Two PTX-200 Patents 2 pages 271.1KB
Regulatory Filings
2016-08-03 English
Change of Director's Interest Notice 4 pages 271.7KB
Director's Dealing
2016-07-26 English
June 2016 Appendix 4C - Quarterly 7 pages 203.9KB
Interim / Quarterly Report
2016-07-19 English
Amended Share Trading Policy 7 pages 447.9KB
Regulatory Filings
2016-07-19 English
Change in substantial holding 2 pages 135.2KB
Regulatory Filings
2016-07-19 English
Change to exercise price of options 2 pages 220.0KB
Capital/Financing Update
2016-07-19 English
Section 708A Cleansing Notice and Appendix 3B 14 pages 916.1KB
Capital/Financing Update
2016-07-17 English
Shortfall Placement Oversubscribed 2 pages 164.9KB
Capital/Financing Update
2016-07-11 English
Change in substantial holding 3 pages 230.3KB
Major Shareholding Notification
2016-07-04 English
Change of Director's Interest Notices x2 6 pages 307.0KB
Director's Dealing
2016-06-30 English
Ceasing to be a substantial holder 2 pages 100.3KB
Major Shareholding Notification
2016-06-30 English
Completion of Entitlement Issue Allotment and Appendix 3B 14 pages 201.4KB
Capital/Financing Update
2016-06-29 English
Entitlement Offer Closure and Shortfall Notification 2 pages 238.3KB
Capital/Financing Update
2016-06-28 English
Change in substantial holding 2 pages 231.0KB
Major Shareholding Notification
2016-06-23 English
Becoming a substantial holder 2 pages 117.5KB
Regulatory Filings
2016-06-23 English
Tranche 2 Capital Raising Complete and Appendix 3B 14 pages 385.3KB
Capital/Financing Update
2016-06-22 English
Results of Meeting 2 pages 358.6KB
Declaration of Voting Results & Voting Rights Announcements
2016-06-21 English
Extension of Closing Date of Entitlement Offer 2 pages 82.6KB
Capital/Financing Update
2016-06-15 English
Yale Joins PTX's Phase 1b/2 AML Clinical Trial 2 pages 272.1KB
Regulatory Filings
2016-06-14 English
Despatch of Pro-rata Rights Issue Offer Documents 1
Capital/Financing Update
2016-06-05 English
Replacement Entitlement Offer Prospectus 44 pages 1.2MB
Regulatory Filings
2016-06-02 English
Rights Issue Update 1 page 114.7KB
Capital/Financing Update
2016-05-31 English
Change in substantial holding 2 pages 233.4KB
Major Shareholding Notification
2016-05-25 English
Tranche 1 Capital Raising Complete and Appendix 3B 14 pages 430.3KB
Capital/Financing Update
2016-05-23 English
Notice of General Meeting/Proxy Form 14 pages 918.9KB
Proxy Solicitation & Information Statement
2016-05-22 English
PTX Secures $7.0M Capital Raising 4 pages 147.3KB
Capital/Financing Update
2016-05-17 English
Offer Document 77 pages 4.5MB
Capital/Financing Update
2016-05-17 English
Appendix 3B 12 pages 214.7KB
Capital/Financing Update
2016-05-17 English
Letter to Eligible Shareholders 3 pages 220.5KB
Capital/Financing Update
2016-05-17 English
Letter to Ineligible shareholders 2 pages 203.7KB
Capital/Financing Update
2016-05-17 English
Letter to Optionholders 2 pages 200.9KB
Capital/Financing Update
2016-05-17 English
Trading Halt 2 pages 546.1KB
Capital/Financing Update
2016-05-15 English
March 2016 Appendix 4C - Quarterly 7 pages 323.4KB
Interim / Quarterly Report
2016-04-20 English
Investor Presentation - April 2016 28 pages 2.2MB
Investor Presentation
2016-04-12 English
RedChip Issues Research on Prescient Therapeutics 1
Regulatory Filings
2016-03-30 English
Edison Investment Research Initiates Coverage 1 pag
Regulatory Filings
2016-03-02 English
PTX Featured on Bloomberg's - The Redchip Money Report 1
Regulatory Filings
2016-03-01 English
PTX-200 Breast Cancer Trial Progresses 2 pages 135.7KB
Capital/Financing Update
2016-02-16 English
Appendix 4D and Half Year Financial Report 23 pages 675.2KB
Interim / Quarterly Report
2016-02-16 English
Steven Yatomi-Clarke Appointed CEO 3 pages 267.9KB
Board/Management Information
2016-02-14 English
Appendix 3B 12 pages 520.4KB
Capital/Financing Update
2016-02-04 English
December 2015 Appendix 4C - Quarterly 7 pages 452.3KB
Interim / Quarterly Report
2016-01-24 English
PTX Presents at NobleCon12 1 page 196.3KB
Regulatory Filings
2016-01-20 English
Response to ASX Price Query 4 pages 689.1KB
Regulatory Filings
2016-01-18 English
Yale Hematolgy Leader Joins PTX Scientific Advisory Board 2 pages 205.1KB
Board/Management Information
2016-01-13 English
PTX to present at Biotech Showcase 2016 in San Francisco 27 pages 2.3MB
Investor Presentation
2016-01-10 English
FDA Allows PTX IND for Leukemia Phase Ib & II Trials 4 pages 333.6KB
Regulatory Filings
2016-01-07 English